Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Regenxbio (RGNX) over the last 10 years, with Q3 2025 value amounting to $51.7 million.

  • Regenxbio's Shares Outstanding (Diluted Average) rose 175.0% to $51.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.7 million, marking a year-over-year increase of 175.0%. This contributed to the annual value of $49.5 million for FY2024, which is 1320.48% up from last year.
  • Latest data reveals that Regenxbio reported Shares Outstanding (Diluted Average) of $51.7 million as of Q3 2025, which was up 175.0% from $51.5 million recorded in Q2 2025.
  • Over the past 5 years, Regenxbio's Shares Outstanding (Diluted Average) peaked at $51.7 million during Q3 2025, and registered a low of $42510.0 during Q2 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $43.8 million (2021), whereas its average is $34.1 million.
  • In the last 5 years, Regenxbio's Shares Outstanding (Diluted Average) crashed by 9989.03% in 2021 and then skyrocketed by 10150458.72% in 2023.
  • Quarter analysis of 5 years shows Regenxbio's Shares Outstanding (Diluted Average) stood at $43.9 million in 2021, then decreased by 1.73% to $43.2 million in 2022, then rose by 1.35% to $43.7 million in 2023, then increased by 13.2% to $49.5 million in 2024, then rose by 4.4% to $51.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $51.7 million for Q3 2025, versus $51.5 million for Q2 2025 and $51.4 million for Q1 2025.